Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Marcacci

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diagnostics (Basel, Switzerland)|December 24, 2021
Mechanisms of Neuronal Damage in Acute Hepatic PorphyriasAndrea Ricci, Elena Di Pierro, Matteo Marcacci, et al.
Orphanet Journal of Rare Diseases|April 8, 2022
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectivesMatteo Marcacci, Andrea Ricci, Chiara Cuoghi, et al.
Thrombosis Research|April 12, 2016
Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosisPaolo Ventura, Giorgia Venturelli, Matteo Marcacci, et al.
Internal and Emergency Medicine|March 5, 2018
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study)Luca Depietri, Marco Marietta, Stefania Scarlini, et al.
European Journal of Internal Medicine|June 4, 2020
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad?Paolo Ventura, Elena Corradini, Elena Di Pierro, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Endothelial Dysfunction in Acute Hepatic PorphyriasAndrea Ricci, Gilda Sandri, Matteo Marcacci, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Recognized and Emerging Features of Erythropoietic and X-Linked ProtoporphyriaElena Di Pierro, Francesca Granata, Michele De Canio, et al.
Microorganisms|June 15, 2023
A Fatal Case of <i>Pseudomonas aeruginosa</i> Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature ReviewNicole Barp, Matteo Marcacci, Emanuela Biagioni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 17, 2026
Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria RegistryCarl M Baravelli, Sverre Sandberg, Marte H Hammersland, et al.
European Journal of Dermatology : EJD|October 6, 2020
Clinical and molecular epidemiology of erythropoietic protoporphyria in ItalyPaolo Ventura, Valentina Brancaleoni, Elena Di Pierro, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diagnostics (Basel, Switzerland)|December 24, 2021
Mechanisms of Neuronal Damage in Acute Hepatic PorphyriasAndrea Ricci, Elena Di Pierro, Matteo Marcacci, et al.
Orphanet Journal of Rare Diseases|April 8, 2022
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectivesMatteo Marcacci, Andrea Ricci, Chiara Cuoghi, et al.
Thrombosis Research|April 12, 2016
Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosisPaolo Ventura, Giorgia Venturelli, Matteo Marcacci, et al.
Internal and Emergency Medicine|March 5, 2018
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study)Luca Depietri, Marco Marietta, Stefania Scarlini, et al.
European Journal of Internal Medicine|June 4, 2020
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad?Paolo Ventura, Elena Corradini, Elena Di Pierro, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Endothelial Dysfunction in Acute Hepatic PorphyriasAndrea Ricci, Gilda Sandri, Matteo Marcacci, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Recognized and Emerging Features of Erythropoietic and X-Linked ProtoporphyriaElena Di Pierro, Francesca Granata, Michele De Canio, et al.
Microorganisms|June 15, 2023
A Fatal Case of <i>Pseudomonas aeruginosa</i> Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature ReviewNicole Barp, Matteo Marcacci, Emanuela Biagioni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 17, 2026
Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria RegistryCarl M Baravelli, Sverre Sandberg, Marte H Hammersland, et al.
European Journal of Dermatology : EJD|October 6, 2020
Clinical and molecular epidemiology of erythropoietic protoporphyria in ItalyPaolo Ventura, Valentina Brancaleoni, Elena Di Pierro, et al.
Pageof 2